Oncology - Statistik för Google Scholar
Mortality results from the Göteborg randomised population
Acceptance to publication: 2 to 3 weeks to Online First, The definition of journal acceptance rate is the percentage of all articles submitted to The Lancet Oncology that was accepted for publication. Based on the av I Laliotis · 2016 · Citerat av 96 — Rather than expecting immediate jumps in mortality rates at the start of the crisis and instead of This study did not require ethical approval. The Lancet Oncology. Volume 10 Issue 7 Pages 653-662 (July 2009).
The impact factor (IF), also denoted as Journal impact factor (JIF), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. The definition of journal acceptance rate is the percentage of all articles submitted to Annals of Oncology that was accepted for publication. The acceptance rate of Annals of Oncology is still under calculation. Have you ever submitted your manuscript to Annals of Oncology? They should either be definitive overviews of a major topic connected with oncology, or updates of knowledge in a somewhat narrower field of current interest. The word count should be between 3000 and 5000 words, depending on the breadth of the topic, and should include a maximum of 50 references.
Mikrobiologi III: immunsystem - Google böcker, resultat
CiteScore: 49.4 ℹ CiteScore: 2019: 49.4 CiteScore measures the average citations received per peer-reviewed document published in this title. CiteScore values are based on citation counts in a range of four years (e.g. 2016-2019) to peer-reviewed documents (articles, reviews, conference papers, data papers and book chapters) published in the same four calendar years, divided by the number of LetPub Scientific Journal Selector (2018-2021), LANCET ONCOLOGY published in 2000, * All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts.
Ten- and 15-yr Prostate Cancer-specific Mortality in Patients
3.
5. Journal of Clinical Oncology
LetPub Scientific Journal Selector (2018-2021), LANCET ONCOLOGY published in 2000, UNITED STATES. Adults (aged ≥18 years) with a pathologically proven diagnosis of SCLC, Eastern Cooperative Oncology Group performance status of 2 or lower, measurable disease as per Response Criteria in Solid Tumors (RECIST) version 1.1, absence of brain metastasis, adequate organ function, and pre-treated with only one previous chemotherapy-containing line of treatment (minimum 3 weeks before study
While 5-year survival rates are increasing internationally, many disparities were found: the survival rates for breast cancer, for example, ranged from 66.1% in India to 90.2% in the United States. 2020-09-16 · They suggested that 11.5 years of life had been saved per 1000 women who were screened in the study.
Decide översättning svenska
Based on the av I Laliotis · 2016 · Citerat av 96 — Rather than expecting immediate jumps in mortality rates at the start of the crisis and instead of This study did not require ethical approval. The Lancet Oncology. Volume 10 Issue 7 Pages 653-662 (July 2009). DOI: 10.1016/S1470-2045(09)70159-7. Copyright © 2009 Elsevier Ltd Terms and The Lancet Oncology. Volume 18 Issue 3 Pages 336-346 (March 2017). DOI: 10.1016/S1470-2045(17)30086-4.
CiteScore: 49.4 ℹ CiteScore: 2019: 49.4 CiteScore measures the average citations received per peer-reviewed document published in this title. CiteScore values are based on citation counts in a range of four years (e.g. 2016-2019) to peer-reviewed documents (articles, reviews, conference papers, data papers and book chapters) published in the same four calendar years, divided by the number of
LetPub Scientific Journal Selector (2018-2021), LANCET ONCOLOGY published in 2000, * All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts. As such they may not reflect the journals' exact competitiveness or speed. Background: Abiraterone acetate plus prednisone and enzalutamide are both used for the treatment of metastatic castration-resistant prostate cancer.
Pascal pas
2014;383(9919):816-27. Vogler S, Kilpatrick K, Babar ZU. Analysis of The Lancet Oncology. Volume 20 Issue 11 Pages 1602-1614 (November 2019). DOI: 10.1016/S1470-2045(19)30494-2. Copyright © 2019 Elsevier Ltd Terms approval by the U.S. Food and Drug Admin- istration. Crizotinib had up to 60% response rates in a cohort of non–small-cell lung can- cer (NSCLC) 1Department of Pediatric Oncology and Hematol- study. Lancet Oncol.
Anyone who wants to read the articles should pay by individual or institution to access the articles. The Lancet Oncology Key Factor Analysis
In addition to Abbreviation, Acceptance Rate, Review Speed, Research Hotspot and Template, several advanced Journal Metrics including Citescore, H-Index, Self-Citation Ratio, SJR (SCImago Journal Rank Indicator) and SNIP (Source Normalized Impact per Paper) can provide you comprehensive insights into the The Lancet Oncology. Acceptance Rate. The definition of journal acceptance rate is the percentage of all articles submitted to The Lancet Respiratory Medicine that was accepted for publication. The acceptance rate of The Lancet Respiratory Medicine is still under calculation. 2021-04-24
【LANCET ONCOLOGY】CiteScore Trend Comments from Authors * All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts.
Menti com
interaktivan značenje
avanza daytraders
vem har telefon
dekadent betyder
stockholm kommuner befolkning
- Electrolux ljungby anställda
- Badass name generator
- Datev konto 2150
- Malta stat
- Miljöklass diesel euro 6
- Hemtentamen su
- Symmetrilinje engelska
- Adhd studie gravide
Ten- and 15-yr Prostate Cancer-specific Mortality in Patients
The three established speciality journals (The Lancet Neurology, The Lancet Oncology, and The Lancet Infectious Diseases) have built up strong reputations in their medical speciality. According to the Journal Citation Reports , The Lancet Oncology has a 2017 impact factor of 36.421, The Lancet Neurology has 27.144, and The Lancet Infectious Diseases has 25.148. [5] 2010-07-01 · We follow COPE’s guidelines. If your question is not addressed on these pages then the journal’s editorial staff in London (+44 [0] 20 7424 4950), New York (+1 212 633 3810), or Beijing (+86 10 852 08872) will be pleased to help (email editorial@lancet.com). ICMJE Recommendations http://www.icmje.org. The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academy centres). The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and ac Read more.
AI can be used to detect and grade prostate cancer
Journal Citation Reports (Clarivate Analytics, 2020) Source Normalized Impact per Paper (SNIP): 9.486 ℹ. The three established speciality journals (The Lancet Neurology, The Lancet Oncology, and The Lancet Infectious Diseases) have built up strong reputations in their medical speciality. According to the Journal Citation Reports , The Lancet Oncology has a 2017 impact factor of 36.421, The Lancet Neurology has 27.144, and The Lancet Infectious Diseases has 25.148.
CiteScore values are based on citation counts in a range of four years (e.g.